Open navigation
Search
Search

Select your region

Nadège Beynon
Senior Associate

Nadège Beynon

Patent Attorney | UPC Representative

Languages
  • French
  • English
Social media

Nadège is a European and UK Chartered Patent Attorney specialising in the life sciences and chemistry sectors, including pharmaceuticals, biotechnologies, cosmetics, and food products. Nadège is also a representative before the Unified Patent Court.

Nadège is experienced in drafting and prosecuting patent applications, opposition and appeal work before the European Patent Office, as well as in providing freedom-to-operate and patentability opinions.

Prior to joining the patent profession, Nadège gained in-house experience working in regulatory affairs in the pharmaceutical industry. As a result, Nadège has a keen interest in the interplay between IP and regulatory considerations and regularly publishes on this topic.

Memberships & Roles

  • Fellow of the Chartered Institute of Patent Attorneys.
  • Member of the European Patent Institute.

Education

  • 2023 - Representative before the Unified Patent Court (UPC)
  • 2019 – European Patent Attorney (EPA)
  • 2019 – Chartered UK Patent Attorney (CPA)
  • 2015 - MSc and Certificate in IP Law, Queen Mary University of London, London, UK.
  • 2012 - PhD, University of Nottingham, Nottingham, UK.
  • 2008 - Diplôme d'Ingénieur and MSc, ENSCM, Montpellier, France.
  • 2006 – Maîtrise, Pierre and Marie Curie University, Paris France.
  • 2005 - BSc, Université de Poitiers, Poitiers, France.

Insights by Nadège

Better Together? Patents on Combination Therapies at the EPO

22 Jan 2026 16 min read

Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC

08 Jan 2026 13 min read

A phase III clinical trial protocol does not by itself provide a reasonable expectation of success of the investigated treatment (T 122/23)

20 Aug 2025 15 min read

Defining a patient population based on clinical trial results (T 2481/22)

25 Jun 2025 9 min read
Back to top Back to top
You will now find all Law-Now content on CMS.law